Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Diabetes Obes Metab. 2022 Feb 15;24(6):1000–1009. doi: 10.1111/dom.14662

Table 3.

Association between changes in physical activity and concurrent changes (Δ) in adiposity during weight loss intervention

Changes of Physical Activity (steps/day)
Baseline to 6 months1 Baseline to 24 months1 6 months to 24 months2
N3 β (SE) P FDR (qvalue) N3 β (SE) P FDR (qvalue) N3 β (SE) P FDR (qvalue)
Δ Body weight, kg 382 −0.48 (0.11) <0.0001 0.0002 256 −0.63 (0.14) <0.0001 0.0002 340 −0.31 (0.09) 0.0003 0.0015
Δ Waist circumference, cm 382 −0.49 (0.12) <0.0001 0.0002 256 −0.73 (0.14) <0.0001 0.0002 340 −0.37 (0.09) <0.0001 0.001
Δ Body composition
Δ Total fat, kg 218 −0.49 (0.11) <0.0001 0.0002 145 −0.64 (0.15) <0.0001 0.0002 185 −0.29 (0.09) 0.002 0.005
Δ Total lean, kg 218 −0.15 (0.06) 0.0096 0.012 145 −0.18 (0.08) 0.033 0.0471 185 −0.08 (0.06) 0.1624 0.1804
Δ Total fat mass % 218 −0.35 (0.07) <0.0001 0.0002 145 −0.42 (0.09) <0.0001 0.0002 185 −0.20 (0.06) 0.0015 0.005
Δ Trunk fat % 218 −0.46 (0.10) <0.0001 0.0002 145 −0.50 (0.12) <0.0001 0.0002 185 −0.23 (0.08) 0.0031 0.0052
Δ Adipose tissue mass
Δ Total 73 −0.22 (0.10) 0.0352 0.0391 53 −0.21 (0.13) 0.1122 0.1247 76 −0.20 (0.07) 0.0044 0.0063
Δ Visceral 90 −0.14 (0.04) 0.0011 0.0017 66 −0.14 (0.05) 0.0045 0.0075 90 −0.05 (0.03) 0.0784 0.098
Δ Deep subcutaneous 90 −0.13 (0.04) 0.0012 0.0017 66 −0.06 (0.04) 0.1274 0.1274 90 −0.04 (0.03) 0.1905 0.1905
Δ Superficial 73 −0.11 (0.06) 0.0832 0.0832 53 −0.13 (0.08) 0.1037 0.1247 76 −0.13 (0.04) 0.0028 0.0052

Beta represents the change in outcomes for the per 1000 increases in steps/day; FDR (qvalue) false discovery rate

1

Data with GLM model adjusting for age at the baseline examination, sex, race, diet group, body mass index at the baseline examination, baseline steps, and variable of interest at the baseline examination (except for body weight).

2

Data with GLM model adjusting for age at the baseline examination, sex, race, diet group, body mass index at the baseline examination, steps at 6 months, and variable of interest at 6 months.

3

N, Number of participants eligible for the analysis.